Brasilibactin A, a cytotoxic compound from actinomycete Nocardia brasiliensis

Journal of Natural Products

Volumn 68, Issue 3, 2005, Pages 462-464

  Tsuda, Masashi ^a   Yamakawa, Masaaki ^a   Oka, Seiko ^a   Tanaka, Yasushi ^b   Hoshino, Yasutake ^c   Mikami, Yuzuru ^c   Sato, Ayumi ^d   Fujiwara, Hironori ^d   Ohizumi, Yasushi ^d   Kobayashi, Jun'ichi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b Higeta Shoyu Co Ltd   (Japan)

^c CHIBA UNIVERSITY   (Japan)

^d TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRASILIBACTIN A; CASPASE 3; CYTOTOXIC AGENT; NATURAL PRODUCT; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; STEARIC ACID DERIVATIVE;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; CANCER CELL CULTURE; CARBON NUCLEAR MAGNETIC RESONANCE; CELL STRAIN HL 60; CELL STRAIN KB; CONCENTRATION RESPONSE; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG STRUCTURE; ENZYME ACTIVITY; FUNGAL STRAIN; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IC 50; MICROCOCCUS LUTEUS; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NOCARDIA BRASILIENSIS; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; STAPHYLOCOCCUS AUREUS; STRUCTURE ANALYSIS; ANIMAL; CHEMISTRY; DRUG SCREENING; ISOLATION AND PURIFICATION; LEUKEMIA L 1210; NOCARDIA;

NOCARDIA BRASILIENSIS; UNCULTURED ACTINOMYCETE;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; KB CELLS; LEUKEMIA L1210; MICE; NOCARDIA; STEARIC ACIDS;

EID: 20244384148     PISSN: 01633864     EISSN: None     Source Type: Journal    
DOI: 10.1021/np0496385     Document Type: Article

References (16)

1. Shigemori, H.; Tanaka, Y.; Yazawa, K.; Mikami, Y.; Kobayashi, J. Tetrahedron 1996, 52, 9031-9034.
2. Tsuda, M.; Sato, Y.; Tanaka, Y.; Yazawa, K.; Mikami, Y.; Kobayashi, J. J. Chem. Soc., Perkin Trans. 1 1996, 1773-1775.
3. Kobayashi, J.; Tsuda, M.; Nemoto, A.; Tanaka, Y.; Yazawa, K.; Mikami, Y. J. Nat. Prod. 1997, 60, 719-720.
4. Shigemori, H.; Komaki, H.; Yazawa, K.; Mikami, Y.; Nemoto, A.; Tanaka, Y.; Sasaki, T.; In, Y.; Ishida, T.; Kobayashi, J. J. Org. Chem. 1998, 63, 6900-6904.
5. Tsuda, M.; Nemoto, A.; Komaki, H.; Tanaka, Y.; Yazawa, K.; Mikami Y.; Kobayashi, J. J. Nat. Prod. 1999, 62, 1640-1642.
6. 13C NMR data for the dihydrooxazole were referred from dolastatin I.; Sone, H.; Kigoshi, H.; Yamada, K. Tetrahedron Lett. 1997, 53, 8149-8154. On the other hand, those for the dihydrothiazole were referred from curasin A: Gerwick, W. J.; Proteau, P. J. Nagle, D. G.; Hamel, E.; Blokhin, A.; Slate, D. L. J. Org. Chem. 1994, 59, 1243-1245.
7. 13C NMR data for the dihydrooxazole were referred from dolastatin I.; Sone, H.; Kigoshi, H.; Yamada, K. Tetrahedron Lett. 1997, 53, 8149-8154. On the other hand, those for the dihydrothiazole were referred from curasin A: Gerwick, W. J.; Proteau, P. J. Nagle, D. G.; Hamel, E.; Blokhin, A.; Slate, D. L. J. Org. Chem. 1994, 59, 1243-1245.
8. Matsumori, N.; Kaneno, D.; Murata, M.; Nakamura, H.; Tachibana, K. J. Org. Chem. 1999, 64, 866-876.
9. Vergne, A. F.; Walz, A. J.; Miller, M. J. Nat. Prod. Rep. 2000, 17, 99-116, and references therein.
10. Rathledge, C.; Snow, G. A. Biochem. J. 1974, 139, 407-413.
11. Murakami, Y.; Kato, M.; Nakajima, M.; Matsuoka, H.; Kawai, K.; Shinya, K.; Seto, H. J. Anibiot. 1996, 49, 839-845.
12. Tsukamoto, M.; Murooka, K.; Nakajima, S.; Abe, H.; Suzuki, K.; Hirano, H.; Kondo, K.; Kojima, K.; Suda, H. J. Antibiot. 1997, 50, 815-821.
13. Suenaga, K.; Kokubo, S.; Shinohara, C.; Tsuji, T.; Uemura, D. Tetrahedron Lett. 1999, 40, 1945-1948.
14. Japan Patent 344768A, 2000.
15. Viswanath, V.; Wu, Y.; Boonplueang, R.; Chen, S.; Stevenson, F. F.; Yantiri, F.; Yang, L.; Beal, M. F. J. Neurosci. 2001, 21, 9519-9528.
16. Kishi, K.; Yazawa, K.; Takahashi, K.; Mikami, Y.; Arai, T. J. Antibiot. 1984, 37, 874-852.